182 related articles for article (PubMed ID: 25173198)
1. Effect of PUFA on patients with hypertension: a hospital based study.
Shantakumari N; Eldeeb RA; Ibrahim SA; Sreedharan J; Otoum S
Indian Heart J; 2014; 66(4):408-14. PubMed ID: 25173198
[TBL] [Abstract][Full Text] [Related]
2. Marine n-3 polyunsaturated fatty acids affect the blood pressure control in patients with newly diagnosed hypertension - a 1-year follow-up study.
Bagge CN; Strandhave C; Skov CM; Svensson M; Schmidt EB; Christensen JH
Nutr Res; 2017 Feb; 38():71-78. PubMed ID: 28291551
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids and blood pressure.
Cabo J; Alonso R; Mata P
Br J Nutr; 2012 Jun; 107 Suppl 2():S195-200. PubMed ID: 22591893
[TBL] [Abstract][Full Text] [Related]
4. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials.
Appel LJ; Miller ER; Seidler AJ; Whelton PK
Arch Intern Med; 1993 Jun; 153(12):1429-38. PubMed ID: 8141868
[TBL] [Abstract][Full Text] [Related]
5. Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients.
Prisco D; Paniccia R; Bandinelli B; Filippini M; Francalanci I; Giusti B; Giurlani L; Gensini GF; Abbate R; Neri Serneri GG
Thromb Res; 1998 Aug; 91(3):105-12. PubMed ID: 9733153
[TBL] [Abstract][Full Text] [Related]
6. Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes.
Colussi G; Catena C; Novello M; Bertin N; Sechi LA
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):191-200. PubMed ID: 27692558
[TBL] [Abstract][Full Text] [Related]
7. Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive rats.
de Wilde MC; Hogyes E; Kiliaan AJ; Farkas T; Luiten PG; Farkas E
Brain Res; 2003 Oct; 988(1-2):9-19. PubMed ID: 14519522
[TBL] [Abstract][Full Text] [Related]
8. Association of polyunsaturated/saturated fatty acids to metabolic syndrome cardiovascular risk factors and lipoprotein (a) in hypertensive type 2 diabetic patients.
Bennacer AF; Haffaf E; Kacimi G; Oudjit B; Koceir EA
Ann Biol Clin (Paris); 2017 Jun; 75(3):293-304. PubMed ID: 28540852
[TBL] [Abstract][Full Text] [Related]
9. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
Abeywardena MY; Patten GS
Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036
[TBL] [Abstract][Full Text] [Related]
10. Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting.
Schmöcker C; Zhang IW; Kiesler S; Kassner U; Ostermann AI; Steinhagen-Thiessen E; Schebb NH; Weylandt KH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316682
[TBL] [Abstract][Full Text] [Related]
11. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study.
Cicero AF; Derosa G; Di Gregori V; Bove M; Gaddi AV; Borghi C
Clin Exp Hypertens; 2010 Jan; 32(2):137-44. PubMed ID: 20374188
[TBL] [Abstract][Full Text] [Related]
12. Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD.
Szabo de Edelenyi F; Vergnaud AC; Ahluwalia N; Julia C; Hercberg S; Blacher J; Galan P
Br J Nutr; 2012 Mar; 107(6):921-7. PubMed ID: 21801476
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats.
Jayasooriya AP; Begg DP; Chen N; Mathai ML; Sinclair AJ; Wilkinson-Berka J; Wark JD; Weisinger HS; Weisinger RS
Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):67-72. PubMed ID: 18083506
[TBL] [Abstract][Full Text] [Related]
14. Moderate Dietary Supplementation with Omega-3 Fatty Acids Does Not Impact Plasma Von Willebrand Factor Profile in Mildly Hypertensive Subjects.
Bürgin-Maunder CS; Brooks PR; Hitchen-Holmes D; Russell FD
Biomed Res Int; 2015; 2015():394871. PubMed ID: 26290867
[TBL] [Abstract][Full Text] [Related]
15. Short term omega-3 polyunsaturated fatty acid supplementation induces favorable changes in right ventricle function and diastolic filling pressure in patients with chronic heart failure; A randomized clinical trial.
Chrysohoou C; Metallinos G; Georgiopoulos G; Mendrinos D; Papanikolaou A; Magkas N; Pitsavos C; Vyssoulis G; Stefanadis C; Tousoulis D
Vascul Pharmacol; 2016 Apr; 79():43-50. PubMed ID: 26807502
[TBL] [Abstract][Full Text] [Related]
16. Fish meal supplementation and ambulatory blood pressure in patients with hypertension: relevance of baseline membrane fatty acid composition.
Colussi G; Catena C; Dialti V; Pezzutto F; Mos L; Sechi LA
Am J Hypertens; 2014 Mar; 27(3):471-81. PubMed ID: 24390292
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
Downie LE; Ng SM; Lindsley KB; Akpek EK
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
[TBL] [Abstract][Full Text] [Related]
18. Intakes of omega-3 polyunsaturated fatty acids and blood pressure change over time: Possible interaction with genes involved in 20-HETE and EETs metabolism.
Tagetti A; Ericson U; Montagnana M; Danese E; Almgren P; Nilsson P; Engström G; Hedblad B; Minuz P; Orho-Melander M; Fava C; Melander O
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():126-33. PubMed ID: 25986600
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management.
Cicero AF; Ertek S; Borghi C
Curr Vasc Pharmacol; 2009 Jul; 7(3):330-7. PubMed ID: 19601857
[TBL] [Abstract][Full Text] [Related]
20. n-3 PUFA Supplementation Alters Retinal Very-Long-Chain-PUFA Levels and Ratios in Diabetic Animal Models.
Gorusupudi A; Chang FY; Nelson K; Hageman GS; Bernstein PS
Mol Nutr Food Res; 2019 Aug; 63(15):e1801058. PubMed ID: 31106474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
